Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada

  • End date
    Dec 31, 2022
  • participants needed
  • sponsor
    Canadian Paediatric Society
Updated on 24 April 2022


Active metropolitan area surveillance for hospital admissions related to invasive infection with Neisseria meningitidis will be conducted at the 12 centers in the IMPACT network in collaboration with Public Health officials, local infection specialists and infection control practitioners during the interval from January 1, 2016 to December 31, 2022.


The objectives are 3-fold, including:

  1. description of affected children and adults and the nature and outcome of the infection episodes
  2. incidence rate determination in defined populations, by age, serogroup and study year
  3. detailed study of the organisms recovered from cases

Condition Invasive Meningococcal Disease
Treatment Surveillance
Clinical Study IdentifierNCT04184336
SponsorCanadian Paediatric Society
Last Modified on24 April 2022


Yes No Not Sure

Inclusion Criteria

Neisseria meningitidis isolated or detected by PCR from a
sterile body site or fluid, such as blood, CSF, joint fluid, pleural, peritoneal
pericardial fluid or tissue biopsy -

Exclusion Criteria

patients diagnosed based only on
clinical signs, gram stain, or antigen test
meningococci isolated only from respiratory tract, including conjunctiva, sinuses
middle ear/mastoid, throat, peritonsillar abscess, cervical lymph node, tracheal
aspirate, bronchial lavage etc -
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note